Skip to main content
Diaceutics PLC (AIM:DXRX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
174.17
-0.33 (-0.19%)
Apr 28, 2026, 3:46 PM GMT

Diaceutics Revenue

Diaceutics had revenue of 14.56M GBP in the half year ending June 30, 2025, with 46.76% growth. This brings the company's revenue in the last twelve months to 34.40M, up 31.83% year-over-year. In the year 2024, Diaceutics had annual revenue of 32.16M with 35.69% growth.

Revenue (ttm)
34.40M
Revenue Growth
+31.83%
P/S Ratio
4.24
Revenue / Employee
161.51K
Employees
213
Market Cap
146.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202432.16M8.46M35.69%
Dec 31, 202323.70M4.20M21.51%
Dec 31, 202219.50M5.56M39.88%
Dec 31, 202113.94M1.25M9.82%
Dec 31, 202012.70M-746.00K-5.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.64B
GSK plc 32.67B
Haleon 11.03B
Smith & Nephew 4.58B
Optima Health 113.75M
Tristel 49.54M
Scancell Holdings 4.71M
EKF Diagnostics Holdings 51.56M
Revenue Rankings

Diaceutics News

More News